Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-12

Clinical Trial Update: SFGT for Persistent Anxiety and Depression [NA]

View source ↗

Summary

This document provides a completed clinical trial update for SFGT aimed at persistent anxiety and depressive symptoms. The trial was sponsored by GGZ Noord-Holl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: GGZ Noord-Holland-Noord | Conditions: Depressive Symptoms, Anxiety Disorders | NA | Status: COMPLETED